Evidence map›Paper›PMID 40508503›Full record

ArticleMaterials (Basel, Switzerland)2025

Specifics of the Molecular Conformations and Physicochemical Properties of Merocyanine Form of Spirooxazine Derivative: Insights from Experimental and Molecular Dynamics Studies.

Andreea Neacsu, Viorel Chihaia, Valentin Alexiev, Georgi B Hadjichristov, Stela Minkovska

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andreea NeacsuIlie Murgulescu Institute of Physical Chemistry, Romanian Academy, Spl. Independentei 202, 060021 Bucharest, Romania.ORCID 0000-0003-3390-8640
Viorel ChihaiaIlie Murgulescu Institute of Physical Chemistry, Romanian Academy, Spl. Independentei 202, 060021 Bucharest, Romania.ORCID 0000-0002-3910-9105
Valentin AlexievInstitute of Catalysis, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 11, BG-1113 Sofia, Bulgaria.
Georgi B HadjichristovGeorgi Nadjakov Institute of Solid State Physics, Bulgarian Academy of Sciences, 72 Tzarigradsko Chaussee Blvd., BG-1784 Sofia, Bulgaria.ORCID 0000-0002-7141-3537
Stela MinkovskaInstitute of Catalysis, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 11, BG-1113 Sofia, Bulgaria.ORCID 0000-0001-7870-2019

Funding

"Experimental and Computational Investigations of the Adsorbed Photo-switching Molecules" "Research Innovation and Digitization for Smart Transformation" program 2021-2027 BG16RFPR002-1.014-0006
6 · The paper itself

Abstract

This research focuses on the merocyanine form of a new synthesized spiroindolinonaphthoxazine compound. The merocyanine molecule (abbreviated as MC) has multiple fragments with different degrees of mobility. The conformational changes and the flexibility of MC in presence and in absence of the solvent molecules were studied by Molecular Dynamics simulations, providing insights into how they orient and interact with each other and with solvent molecules. The molecular packing of MC in presence and in absence of solvents with different polarities was thoroughly investigated in order to determine how the physicochemical interactions with the solvent influence the structure and stability of the MC molecule. Furthermore, the powders of MC obtained from its solutions in water, methanol, ethanol, and acetonitrile were experimentally characterized using differential scanning calorimetry, thermogravimetry, Fourier transform infrared spectroscopy, and scanning electron microscopy. Both calculations and experimental results reveal the effect of the solvent polarity on the dissolved MC molecule.

Indexed as

merocyaninemolecular dynamicssolvatochromic propertiessolvent polarityspirooxazines

Identifiers

PMID40508503
PMCPMC12155645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.